Pfizer forecasts sales from COVID vaccine to fall by nearly two-thirds
Shares of Pfizer Inc. PFE, -0.55% dropped 2.2% toward a 3 1/2-month low in premarket trading Tuesday, after the drug maker reported fourth-quarter profit that topped expectations but revenue and the full-year outlook missed. Net income rose to $5.00 billion, or 87 cents a share, from $3.39 billion, or 59 cents a share, in the year-ago period. Excluding nonrecurring items, adjusted earnings per share of $1.14 was above the FactSet consensus of $1.05 billion. Revenue grew 1.9% to $24.
29 billion, but missed the FactSet consensus of $24.38 billion. For 2023, the company expects adjusted EPS of $3.25 to $3.45, below the FactSet consensus of $4.34. Revenue for the year is expected to fall to $67.0 billion to $71.0 billion, from $100.33 billion in 2022, as revenue for the company’s COVID vaccine Comirnaty is expected to drop 64% and for its COVID treatment Paxlovid is expected to fall 58%. Excluding COVID products, revenue is expected to increase 7% to 9%. The stock has lost 6.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Penny Arcade's Acquisitions Inc. Joins Pocket ParagonsPenny Arcade has teamed with Solis Game Studio to add the primary characters from AcquisitionsInc to PocketDragons. Tabletop CardGames
Consulte Mais informação »
Japan Inc strives to lure skilled workers as inflation, labour crunch biteFrom inflation allowances to the reskilling of workers, firms in Japan are stepping up efforts to help employees fight rising prices and a labour crunch, even though some cannot afford pay hikes that do more than offset cost-push inflation.
Consulte Mais informação »
Paxlovid sales forecasts may change with Pfizer view on ChinaClarity from Pfizer Inc this week on whether China's relaxation of its Zero-COVID policy and the surge in infections there will lead to a spike in demand for its antiviral Paxlovid could spur analysts to alter their 2023 sales forecasts for the treatment.
Consulte Mais informação »
‘Shazam’ Star Zachary Levi Sparks Anti-Vaxxer Rumors With Pfizer TweetJust over a month ahead of the premiere of DC’s Shazam! premiere date, its star, Zachary Levi, tweeted that he “hardcore” agrees that Covid-19 vaccine maker Pfizer is a “real danger to the world.”
Consulte Mais informação »
Zachary Levi Says He Agrees That Pfizer Is a Danger to the WorldTwitter is piling onto Zachary Levi after he expressed an opinion that many are taking as anti-vaxx ... even though the 'Shazam!' actor is trying to distance himself from such a position.
Consulte Mais informação »